Order Article Reprints

Ferrara G, Ivaldi F, Mancardi G, Kerlero de Rosbo N, Uccelli A. Bone Marrow Transfer in Relapsing-Remitting EAE Ameliorates Disease at First Remission, with No Synergistic Effect upon Co-Transplantation with Mesenchymal Stem Cells. Vaccines. 2021; 9(7):736. https://doi.org/10.3390/vaccines9070736

Ferrara, Giovanni, Federico Ivaldi, Gianluigi Mancardi, Nicole Kerlero de Rosbo, and Antonio Uccelli. 2021. "Bone Marrow Transfer in Relapsing-Remitting EAE Ameliorates Disease at First Remission, with No Synergistic Effect upon Co-Transplantation with Mesenchymal Stem Cells" Vaccines 9, no. 7: 736. https://doi.org/10.3390/vaccines9070736

Ferrara, G., Ivaldi, F., Mancardi, G., Kerlero de Rosbo, N., & Uccelli, A. (2021). Bone Marrow Transfer in Relapsing-Remitting EAE Ameliorates Disease at First Remission, with No Synergistic Effect upon Co-Transplantation with Mesenchymal Stem Cells. Vaccines, 9(7), 736. https://doi.org/10.3390/vaccines9070736